|Fluorescent antibody stain of Neisseria gonorrhoeae.|
Neisseria is a large genus of bacteria that colonize the mucosal surfaces of many animals. Of the 11 species that colonize humans, only two are pathogens, N. meningitidis and N. gonorrhoeae. Most gonoccocal infections are asymptomatic and self-resolving, and epidemic strains of the meningococcus may be carried in >95% of a population where systemic disease occurs at <1% prevalence.
- 1 Species
- 2 History
- 3 Biochemical identification
- 4 Iron acquisition
- 5 Vaccine
- 6 Antibiotic resistance
- 7 Genetic transformation
- 8 International Pathogenic Neisseria Conference
- 9 References
This genus (family Neisseriaceae) of parasitic bacteria grow in pairs and occasionally tetrads, and thrive best at 98.6 °F (37 °C) in the animal body or serum media.
The genus includes:
- N. gonorrhoeae (also called the gonococcus), which causes gonorrhea.
- N. meningitidis (also called the meningococcus), one of the most common causes of bacterial meningitis and the causative agent of meningococcal septicaemia.
These two species have the ability of 'breaching' the barrier. Local cytokines of the area become secreted to initiate an immune response. However, neutrophils are not able to do their job due to the ability of Neisseria to invade and replicate within neutrophils, as well avoiding phagocytosis and being killed by complement by resisting opsonization by antibodies, which target the pathogen for destruction. Neisseria species are also able to alter their antigens to avoid being engulfed by a process called antigenic variation, which is observed primarily in surface-located molecules. The pathogenic species along with some commensal species, have type IV pili which serve multiple functions for this organism. Some functions of the type IV pili include: mediating attachment to various cells and tissues, twitching motility, natural competence, microcolony formation, extensive intrastrain phase, and antigenic variation.
Fa(fHbp) that is exhibited in N. meningitidis and some commensal species is the main inhibitor of the alternative complement pathway. fHbp protects meningococci from complement-mediated death in human serum experiments, but has also been shown to protect meningococci from antimicrobial peptides in vitro. Factor H binding protein is key to the pathogenesis of N. meningitidis, and is, therefore, important as a potential vaccine candidate. Porins are also an important factor for complement inhibition for both pathogenic and commensal species. Porins are important for nutrient acquisition. Porins are also recognized by TLR2, they bind complement factors (C3b, C4b, factor H, and C4bp (complement factor 4b-binding protein)). Cooperation with pili for CR3-mediated internalization is another function of porins. Ability to translocate into host cells and modulate reactive oxygen species production and apoptosis is made possible by porins, as well. Strains of the same species can express different porins.
This genus also contains several, believed to be commensal, or nonpathogenic, species:
- Neisseria bacilliformis
- Neisseria cinerea
- Neisseria elongata
- Neisseria flavescens
- Neisseria lactamica
- Neisseria macacae
- Neisseria mucosa
- Neisseria polysaccharea
- Neisseria sicca
- Neisseria subflava
- Neisseria flava
However, some of these can be associated with disease.
The genus Neisseria is named after the German bacteriologist Albert Neisser, who in 1879 discovered its first example, Neisseria gonorrheae, the pathogen which causes the human disease gonorrhea. Neisser also codiscovered the pathogen that causes leprosy, Mycobacterium leprae. These discoveries were made possible by the development of new staining techniques which he helped to develop.
All the medically significant species of Neisseria are positive for both catalase and oxidase. Different Neisseria species can be identified by the sets of sugars from which they will produce acid. For example, N. gonorrheae makes acid from only glucose, but N. meningitidis produces acid from both glucose and maltose.
Polysaccharide capsule N. meningitidis has a polysaccharide capsule that surrounds the outer membrane of the bacterium and protects against soluble immune effector mechanisms within the serum. It is considered to be an essential virulence factor for the bacteria. N. gonorrhea possesses no such capsule. Instead of having the usual lipopolysaccharide (LPS), this bacterium, whether a pathogenic or commensal species, has a lipooligosaccharide (LOS) which consists of a core polysaccharide and lipid A. It functions as an endotoxin, protects against antimicrobial peptides, and adheres to the asialoglycoprotein receptor on urethral cells. LOS is highly stimulatory to the human immune system. LOS sialylation (by the enzyme's Lst) prevents complement deposition and phagocytosis by neutrophils. LOS modification by phosphoethanolamine (by the enzyme LptA) provides resistance to antimicrobial peptides and complement. Strains of the same species have the ability to produce different LOS glycoforms.
Iron is absolutely required by all life forms, playing a critical role in a number of essential processes. Free iron, at least what would be readily available to a microbial pathogen, practically does not exist in animals. In vertebrates, the majority of iron is stored inside cells in complices with either ferritin or hemoglobin. Extracellular iron is found in body fluids complexed to either transferrin or lactoferrin.
Pathogens acquire iron by two different strategies
- ‘Siderophore’-mediated iron uptake involves outcompeting transferrin and/or lactoferrin for iron binding. Iron-bound siderophores are then taken into the bacterium by specific receptors.
- Direct uptake of iron-bound host proteins involves the bacteria possessing a high affinity for transferrin, lactoferrin, and hemoglobin (the approach used by the pathogenic Neiserria spp.).
Receptors: HmbRm, HpuA, and HpuB are receptors for haptoglobin-haemoglobin. LbpAB is a receptor for human lactoferrin. TbpAB (Tbp1-Tbp2) is a receptor for human transferrin. All of these receptors are used for iron acquisition for both pathogenic and commensal species.
Diseases caused by N. meningitidis and N. gonorrhoeae are significant health problems worldwide, the control of which is largely dependent on the availability and widespread use of comprehensive meningococcal and gonococcal vaccines. Development of neisserial vaccines has been challenging due to the nature of these organisms, in particular the heterogeneity, variability and/or poor immunogenicity of their outer surface components. As strictly human pathogens, they are highly adapted to the host environment, but have evolved several mechanisms to remain adaptable to changing microenvironments and avoid elimination by the host immune system. Currently, serogroup A, B, C, Y, and W-135 meningococcal infections can be prevented by vaccines. However, the prospect of developing a gonococcal vaccine is remote.
Diseases caused by the pathogenic Neisseria (N. gonorrhoeae and N. meningitidis) have been successfully treated with antibiotics for the past 70 years. However, the prevalence of strains with resistance to antibiotics is increasing. Given the global nature of gonococcal and meningococcal diseases, the worldwide distribution of antibiotics, differing social practices in controlling and monitoring antibiotic availability, and geographical differences in treatment regimens, the global problem of antibiotic resistance likely will continue in the future. By understanding the mechanisms of antibiotic resistance in gonococci and meningococci, resistance to antibiotics currently in clinical practice can be anticipated and the design of novel antimicrobials to circumvent this problem can be undertaken more rationally. The acquisition of cephalosporin resistance in N. gonorrhoeae, particularly ceftriaxone resistance, has greatly complicated the treatment of gonorrhea, with the gonococcus now being classified as a "superbug".
Genetic transformation is the process by which a recipient bacterial cell takes up DNA from a neighboring cell and integrates this DNA into the recipient’s genome by recombination. In N. meningitides and N. gonorrhoeae, DNA transformation requires the presence of short DNA sequences (9-10 monomers residing in coding regions) of the donor DNA. These sequences are called DNA uptake sequences (DUSs). Specific recognition of DUSs is mediated by a type IV pilin. Davidsen et al. reported that in N. meningitides and N. gonorrhoeae, DUSs occur at a significantly higher density in genes involved in DNA repair and recombination (as well as in restriction-modification and replication) than in other annotated gene groups. These authors proposed that the over-representation of DUS in DNA repair and recombination genes may reflect the benefit of maintaining the integrity of the DNA repair and recombination machinery by preferentially taking up genome maintenance genes that could replace their damaged counterparts in the recipient cell. Caugant and Maiden noted that the distribution of DUS is consistent with recombination being primarily a mechanism for genome repair that can occasionally result in generation of diversity, which even more occasionally, is adaptive. It was also suggested by Michod et al. that an important benefit of transformation in N. gonorrhoeae is recombinational repair of oxidative DNA damages caused by oxidative attack by the host’s phagocytic cells.
International Pathogenic Neisseria Conference
The International Pathogenic Neisseria Conference (IPNC), occurring every two years, is a forum for the presentation of cutting-edge research on all aspects of the genus Neisseria. This includes immunology, vaccinology, and physiology and metabolism of N. meningitidis, N. gonorrhoeae and the commensal species. The first IPNC took place in 1978, and the most recent one was in October 2014. Normally, the location of the conference switches between North America and Europe, but it took place in Australia for the first time in 2006, where the venue was located in Cairns.
- Ryan KJ; Ray CG, eds. (2004). Sherris Medical Microbiology (4th ed.). McGraw Hill. ISBN 0-8385-8529-9.
- Tronel H, Chaudemanche H, Pechier N, Doutrelant L, Hoen B (May 2001). "Endocarditis due to Neisseria mucosa after tongue piercing". Clin. Microbiol. Infect. 7 (5): 275–6. doi:10.1046/j.1469-0691.2001.00241.x. PMID 11422256.
- Ullrich, M, ed. (2009). Bacterial Polysaccharides: Current Innovations and Future Trends. Caister Academic Press. ISBN 978-1-904455-45-5.
- "meningococcal group B vaccine". Medscape. WebMD. Retrieved December 16, 2015.
- Seib KL, Rappuoli R (2010). "Difficulty in Developing a Neisserial Vaccine". Neisseria: Molecular Mechanisms of Pathogenesis. Caister Academic Press. ISBN 978-1-904455-51-6.
- Shafer WM, et al. (2010). "Molecular Mechanisms of Antibiotic Resistance Expressed by the Pathogenic Neisseria". Neisseria: Molecular Mechanisms of Pathogenesis. Caister Academic Press. ISBN 978-1-904455-51-6.
- Unemo M, Nicholas RA (December 2012). "Emergence of multidrug-resistant, extensively drug-resistant and untreatable gonorrhea". Future Microbiol. 7 (12): 1401–1422. doi:10.2217/fmb.12.117. PMC . PMID 23231489.
- Cehovin A, Simpson PJ, McDowell MA, Brown DR, Noschese R, Pallett M, Brady J, Baldwin GS, Lea SM, Matthews SJ, Pelicic V (2013). "Specific DNA recognition mediated by a type IV pilin". Proc. Natl. Acad. Sci. U.S.A. 110 (8): 3065–70. doi:10.1073/pnas.1218832110. PMC . PMID 23386723.
- Davidsen T, Rødland EA, Lagesen K, Seeberg E, Rognes T, Tønjum T (2004). "Biased distribution of DNA uptake sequences towards genome maintenance genes". Nucleic Acids Res. 32 (3): 1050–8. doi:10.1093/nar/gkh255. PMC . PMID 14960717.
- Caugant DA, Maiden MC (2009). "Meningococcal carriage and disease--population biology and evolution". Vaccine. 27 Suppl 2: B64–70. doi:10.1016/j.vaccine.2009.04.061. PMC . PMID 19464092.
- Michod RE, Bernstein H, Nedelcu AM (2008). "Adaptive value of sex in microbial pathogens". Infect. Genet. Evol. 8 (3): 267–85. doi:10.1016/j.meegid.2008.01.002. PMID 18295550.